BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 16996389)

  • 21. Co-morbidity and cannabis use in a mental health trust in South East England.
    Trathen B; O'gara C; Sarkhel A; Sessay M; Rao H; Luty J
    Addict Behav; 2007 Oct; 32(10):2164-77. PubMed ID: 17434688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-occurring disorders in the adolescent mental health and substance abuse treatment systems.
    Turner WC; Muck RD; Muck RJ; Stephens RL; Sukumar B
    J Psychoactive Drugs; 2004 Dec; 36(4):455-62. PubMed ID: 15751483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.
    Gum AM; King-Kallimanis B; Kohn R
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):769-81. PubMed ID: 19700949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Views of Australian mental health stakeholders on clients' problematic drug and alcohol use.
    Cleary M; Hunt GE; Matheson S; Walter G
    Drug Alcohol Rev; 2009 Mar; 28(2):122-8. PubMed ID: 19320696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Painting a picture of the client": implementing the Addiction Severity Index in community treatment programs.
    Spear SE; Brown AH; Rawson RA
    J Subst Abuse Treat; 2005 Dec; 29(4):277-82. PubMed ID: 16311180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of co-occurring mood and anxiety disorders among substance-abusing youth.
    Lubman DI; Allen NB; Rogers N; Cementon E; Bonomo Y
    J Affect Disord; 2007 Nov; 103(1-3):105-12. PubMed ID: 17291589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common psychiatric disorders over a lifetime: age of onset, risk and treatment contact in the Nigerian survey of mental health and wellbeing.
    Gureje O; Uwakwe R; Udofia O; Wakil A; Adeyemi O; Enyidah N
    Afr J Med Med Sci; 2008 Sep; 37(3):207-17. PubMed ID: 18982812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do young people attending addiction services differ from those attending youth mental health services?
    Christie G; Merry S; Robinson E
    Drug Alcohol Rev; 2010 Jul; 29(4):406-12. PubMed ID: 20636657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hospitalizations and hospital charges for co-occurring substance use and mental disorders.
    Ding K; Yang J; Cheng G; Schiltz T; Summers KM; Skinstad AH
    J Subst Abuse Treat; 2011 Jun; 40(4):366-75. PubMed ID: 21353443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organizational capacity to address co-occurring substance use and psychiatric disorders: assessing variation by level of care.
    Lambert-Harris C; Saunders EC; McGovern MP; Xie H
    J Addict Med; 2013; 7(1):25-32. PubMed ID: 23188042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substance abuse with mental disorders: specialized public systems and integrated care.
    Burnam MA; Watkins KE
    Health Aff (Millwood); 2006; 25(3):648-58. PubMed ID: 16684728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for mental disorder comorbidity in Australian alcohol and other drug residential treatment settings.
    Mortlock KS; Deane FP; Crowe TP
    J Subst Abuse Treat; 2011 Jun; 40(4):397-404. PubMed ID: 21353441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving integrated general medical and mental health services in community-based practices.
    Kilbourne AM; Irmiter C; Capobianco J; Reynolds K; Milner K; Barry K; Blow FC
    Adm Policy Ment Health; 2008 Sep; 35(5):337-45. PubMed ID: 18506617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-occurring mental and somatic diagnoses of alcohol dependent patients in relation to long-term aftercare alcohol abstinence and well-being.
    Rus-Makovec M; Cebasek-Travnik Z
    Psychiatr Danub; 2008 Jun; 20(2):194-207. PubMed ID: 18587290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-occurring psychiatric and substance use disorders among male detainees in Italy.
    Piselli M; Elisei S; Murgia N; Quartesan R; Abram KM
    Int J Law Psychiatry; 2009; 32(2):101-7. PubMed ID: 19237198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual diagnosis in an inpatient drug-abuse detoxification unit.
    Nocon A; Bergé D; Astals M; Martín-Santos R; Torrens M
    Eur Addict Res; 2007; 13(4):192-200. PubMed ID: 17851240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening substance abuse treatment clients for traumatic brain injury: prevalence and characteristics.
    Walker R; Cole JE; Logan TK; Corrigan JD
    J Head Trauma Rehabil; 2007; 22(6):360-7. PubMed ID: 18025968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of positive substance abuse screen results among adolescent primary care patients.
    Knight JR; Harris SK; Sherritt L; Van Hook S; Lawrence N; Brooks T; Carey P; Kossack R; Kulig J
    Arch Pediatr Adolesc Med; 2007 Nov; 161(11):1035-41. PubMed ID: 17984404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modified therapeutic community treatment for offenders with MICA disorders: substance use outcomes.
    Sullivan CJ; McKendrick K; Sacks S; Banks S
    Am J Drug Alcohol Abuse; 2007; 33(6):823-32. PubMed ID: 17994478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How much do mental disorders contribute to New Zealand's tobacco epidemic?
    Tobias M; Templeton R; Collings S
    Tob Control; 2008 Oct; 17(5):347-50. PubMed ID: 18669558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.